Abstract
Women' s health encompasses all different areas of medicine and it would be a
monumental task to address all of the areas that affect women. This report
will concentrate on disorders that affect the female reproductive system and
other disorders where there is at least a 70% preponderance of women affected
by the disorder. The worldwide prescription drug market for women' s health
consists of total manufacturers' revenues from the following product
categories:
- Autoimmune diseases
- Cancer
- Gynecological and Sexually Transmitted Diseases
- Hormones
- Osteoporosis
- Urinary Disorders
Women' s Health: Worldwide Prescription Drug Markets, represents the fourth
time that Kalorama Information has tackled the women' s health pharmaceutical
market. Revenues from these segments are not reported in total, as certain
segments affect both men and women. The analysis and market data in this
report estimate revenues associated with therapeutics for women only.
Segmentation within each category is by major drug type and by geographic
region (U.S., Europe, Japan, ROW). All market data pertain to the U.S. market
at the manufacturers' level. Data are expressed in current U.S. dollars. The
base year for data was 2007. forecast data are provided for each of the years
2009 through 2013. Historical, base year, and forecast data are provided for
each market segment. Market shares are provided for each market segment for
the 2007 base year.
In addition to market data, the report contains extensive product pipeline
information, competitor profiles, and discussions of the major industry issues
and trends shaping the market.
The information and analysis presented in this report are based on an
extensive survey of senior management in the prescription women' s health drug
industry. Background information was obtained from a comprehensive search of
published literature and reports obtained from various government, business,
medical trade, and international journals. Key information from published
literature was used to conduct interviews with over 40 industry executives and
product managers to validate and obtain expert opinion on current and future
trends in the women' s health industry. Interviews were also used to confirm
and/or adjust market size and market share estimates, as well as in
formulating market projections.
| 
View Cart
